Cairn Investment Group, Inc. Biogen Inc. Transaction History

Cairn Investment Group, Inc.

$181 Million
Q3 2024

A detailed history of Cairn Investment Group, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Cairn Investment Group, Inc. holds 11,516 shares of BIIB stock, worth $1.69 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares

11,516

Previous 11,150 3.28%

Holding current value

$1.69 Million

Previous $2.59 Million 13.66%

% of portfolio

1.23%

Previous 1.51%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$189.07 - $236.8 $69,199 - $86,668	366 Added 3.28%	11,516 $2.23 Million
Q2 2024 Aug 06, 2024	SELL	$190.52 - $236.72 $34,865 - $43,319	-183 Reduced 1.61%	11,150 $2.59 Million
Q1 2024 Apr 15, 2024	BUY	$212.02 - $267.71 $43,888 - $55,415	207 Added 1.86%	11,333 $2.44 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $71,896 - $86,544	323 Added 2.99%	11,126 $2.88 Million
Q3 2023 Nov 06, 2023	BUY	$253.3 - $285.89 $157,552 - $177,823	622 Added 6.11%	10,803 $2.78 Million
Q2 2023 Aug 01, 2023	BUY	$275.25 - $318.06 $99,365 - $114,819	361 Added 3.68%	10,181 $2.9 Million
Q1 2023 Apr 24, 2023	BUY	$256.56 - $292.34 $65,422 - $74,546	255 Added 2.67%	9,820 $2.73 Million
Q4 2022 Jan 11, 2023	BUY	$252.44 - $306.72 $112,335 - $136,490	445 Added 4.88%	9,565 $2.65 Million
Q3 2022 Oct 13, 2022	SELL	$194.69 - $268.46 $17,522 - $24,161	-90 Reduced 0.98%	9,120 $2.44 Million
Q2 2022 Jul 28, 2022	BUY	$187.54 - $223.02 $18,754 - $22,302	100 Added 1.1%	9,210 $1.88 Million
Q1 2022 Apr 26, 2022	BUY	$193.77 - $244.14 $244,150 - $307,616	1,260 Added 16.05%	9,110 $2.03 Million
Q4 2021 Feb 08, 2022	BUY	$223.92 - $287.77 $134,352 - $172,662	600 Added 8.28%	7,850 $1.88 Million
Q3 2021 Nov 09, 2021	BUY	$282.99 - $369.05 $31,977 - $41,702	113 Added 1.58%	7,250 $2.05 Million
Q2 2021 Aug 12, 2021	BUY	$259.0 - $414.71 $45,325 - $72,574	175 Added 2.51%	7,137 $2.47 Million
Q1 2021 May 04, 2021	SELL	$242.95 - $284.63 $31,583 - $37,001	-130 Reduced 1.83%	6,962 $1.95 Million
Q4 2020 Feb 02, 2021	BUY	$236.26 - $355.63 $19,373 - $29,161	82 Added 1.17%	7,092 $1.74 Million
Q3 2020 Nov 02, 2020	BUY	$264.77 - $305.71 $1.54 Million - $1.78 Million	5,835 Added 496.6%	7,010 $1.99 Million
Q2 2020 Jul 21, 2020	SELL	$258.66 - $342.55 $14,226 - $18,840	-55 Reduced 4.47%	1,175 $314,000
Q1 2020 Apr 24, 2020	SELL	$268.85 - $341.04 $53,770 - $68,208	-200 Reduced 13.99%	1,230 $389,000
Q4 2019 Jan 30, 2020	BUY	$220.06 - $304.07 $314,685 - $434,820	1,430 New	1,430 $424,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cairn Investment Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cairn Investment Group, Inc. with notifications on news.

Account

Cairn Investment Group, Inc. Biogen Inc. Transaction History